Adverse Event Reporting

According to the relevant laws and regulations, marketing authorization holders are obliged to carry out the post-marketing surveillance of drugs. This page will collect information related to your unsolicited feedback to the extent permitted.

If the information you provide relates to a adverse event involving Akeso’s products, the relevant patient information and data will be disclosed to Akeso’s pharmacovigilance department in accordance with the applicable laws and regulations, and the relevant personnel may follow up with you on the safety event. The information will be input into Akeso’s pharmacovigilance database and reported to the relevant regulatory departments in accordance with the applicable laws and regulations. Items marked with * are required. Please fill in the information accurately.

Note: The information marked with * is a required option, please fill in accurately.

*Choose your identity:
Adverse Event Reporting

According to the relevant laws and regulations, marketing authorization holders are obliged to carry out the post-marketing surveillance of drugs. This page will collect information related to your unsolicited feedback to the extent permitted. If the information you provide relates to a adverse event involving Akeso’s products, the relevant patient information and data will be disclosed to Akeso’s pharmacovigilance department in accordance with the applicable laws and regulations, and the relevant personnel may follow up with you on the safety event. The information will be input into Akeso’s pharmacovigilance database and reported to the relevant regulatory departments in accordance with the applicable laws and regulations. Items marked with * are required. Please fill in the information accurately.

  • Physician Information
  • Reporter Information
  • Patient Information
  • Product Information
  • Adverse Event
  • Other Information

  • *Does the attending physician want to be followed up?

    Next Step

  • *Your Name

    *Contact Information (Tel. or Email)

    *Employer

    *Do you want to be followed up?​

    Next Step

  • *Patient name

    *Date of Birth

    *Gender

    Next Step

  • *Product Name

    *Lot Number (see drug packaging)​

    Treatment Dates/Therapy Dates

    Dosage and Frequency

    Reason(s) for Medication​

    Next Step

  • *Event name

    *Seriousness Criteria (multiple options available)

    *Event Outcome

    *In your opinion, the event and Akeso’s product are:

    Time Frame

    Next Step

  • * Other Information (please describe the occurrence and development of the adverse event; symptoms and signs; process of diagnosis and treatment; relevant laboratory tests; imaging findings, etc.)

    Confirm Submission

According to the relevant laws and regulations, marketing authorization holders are obliged to carry out the post-marketing surveillance of drugs. This page will collect information related to your unsolicited feedback to the extent permitted. If the information you provide relates to a adverse event involving Akeso’s products, the relevant patient information and data will be disclosed to Akeso’s pharmacovigilance department in accordance with the applicable laws and regulations, and the relevant personnel may follow up with you on the safety event. The information will be input into Akeso’s pharmacovigilance database and reported to the relevant regulatory departments in accordance with the applicable laws and regulations. Please fill in the information accurately.

Submitting